Business Wire

Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN ...

WILMINGTON, Del.--(BUSINESS WIRE)--Positive full results from the BaxHTN Phase III trial showed baxdrostat demonstrated a statistically significant and clinically meaningful reduction in mean seated ...
Seeking Alpha

Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

SALT LAKE CITY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (MYGN), (NASDAQ: MYGN) a leader in genetic testing and precision medicine, today announced the integration of Absolute Risk ...
Altoona Mirror

Understanding risk reduction of statins

Dear Dr. Roach: A cardiologist recently suggested that I should consider taking a statin because of my “borderline” cholesterol level. So, I took a dive into the details of statin therapy. I learned ...
TCTMD

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Elderly patients with atherosclerotic cardiovascular disease (ASCVD) treated long-term with the PCSK9 inhibitor evolocumab (Repatha; Amgen) derive as much clinical benefit as younger people, according ...
Medscape

In Global Trial, PCSK9 Inhibitor Provides Major Protection Against First CV Event

NEW ORLEANS — The first global randomized trial of the PCSK9 inhibitor evolocumab for the prevention of a primary major adverse cardiovascular event (MACE) found a relative reduction in risk similar ...